MedPath

MERCK SHARP & DOHME (UK) LIMITED

πŸ‡¬πŸ‡§United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

EMC:34
CIMA_AEMPS:23
NMPA:2

Drug Approvals

Belzutifan Tablets

Product Name
η»΄εˆ©η‘ž
Approval Number
国药准字HJ20240135
Approval Date
Nov 15, 2024
NMPA

Molnupiravir Capsules

Product Name
εˆ©ε“η‘ž
Approval Number
国药准字HJ20220097
Approval Date
Dec 29, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.